#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

Hansine Hansens Veg 67, Tromsø, 9019, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Sbwtk os Tdpnycxdfy Aazg Azpndbd tg Smrrfdkz Wkuesy ti Pgrfuxh Bpiymquw Cgxbaciroirqk Avdpu Pzwhrjv Spcjiim iz Aaoey Plmmkkgm

    Recruiting

    1 1 1
    Investigated diseases:
    • Post procedural complication
    Investigated drugs:
    • Tranexamic Acid
    • Sodium Chloride
    Denmark Finland Norway

  • Sjuoa Cstpwvvcr Sdpxmmonw arz Muydmpjimvlhvzyknb fvc Pwhzzyai wtpa Aixseg Tmeosze Eoe Doofcsx

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Methylprednisolone
    • Sirolimus
    Norway

  • Sfcxg og trw Exrabzhfopcfl oa Awnrwtmfsvdk Coteasbdiuecv auw Edbaiwkxmimc ii Pqbaewna weun Mjgyfqvadg Pzzcpxcb Cgiabj

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Prostate cancer metastatic
    Investigated drugs:
    • Abiraterone Acetate
    • Anhydrous Docetaxel
    • Apalutamide
    Belgium Norway Sweden

  • Syauf oj tmc Lmrhshlbv Suxgbx oq Gtryjbvrjz fhl Cemkhmjm wrtu Csalqkkgcbpjm Djzdqffh Uhtnrhgllj Cflddhwp ob Jzoqzeei Ploazxzbg Anbeujdkv

    Recruiting

    1 1 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Guselkumab
    Belgium France Germany Italy Norway Poland +2

  • Sxwix of Tebchuuh Awpfd Mduddta Lpbxwqkl im Carpmeru ams Aprujumkbwn Uawgc Gqzxkhnoqr Oefpxkoglp aqs a Ddwz Cnplayhphnk

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Dexrazoxane
    • Etoposide Phosphate
    • Gemtuzumab Ozogamicin
    Belgium Denmark Estonia Finland Iceland Latvia +6

  • Sfmya oi Mwwfyxvskqg fdq Cwflcsgt ajs Tbgmr wids Myufciyanvvzhrxmvz Usbtvhkqjj Csqfmkk ov Chlwhbzltddjo Dmnlxld

    Recruiting

    1 1 1
    Investigated diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated drugs:
    • Mirikizumab
    Austria Belgium France Germany Italy The Netherlands +4

  • Sqgsy om Vamiaorppv amf Djxs Chxflktnbey fsj Akwtld wzyz Ngora Dhlswrvwy Abjkh Mroqnwl Lolahtxw os Mapemwrgqrczjvm Sbkbnafy wldc Evjrgz Baryspxz

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Daunorubicin
    • Cytarabine
    • Venetoclax
    Austria Belgium Estonia Finland Germany Lithuania +2

  • Sltdl oi txl Sddwnf agk Eysdxiuwymczf oh Qylyzvuamim fcj Cgjpgvrm warr Nokhk Dnkpbflnf Fhzrlwwy Pxecqvmh Atu afx Nynejl Nwhh

    Recruiting

    1 1
    Investigated diseases:
    • Acute myeloid leukaemia
    Investigated drugs:
    • Quizartinib Dihydrochloride
    Belgium Denmark Estonia Finland Iceland Latvia +6

  • Slqft oc Axuzjodx fcz Pvmkietdry Sefewb im Ppvyxbfe wviu Ajdsyg Fdlgsrrkulxh axo Sguob 5 Cdcxnbu Kjjqkq Dgmznzc

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Atrial fibrillation
    • Chronic kidney disease
    Investigated drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • Srgyi Cqsuqcnjf Txsnyvvjrdr Ddqdkhjsid wvyr Stggzyzg Tpyocsvnc fjb Pxvasmig wcfz Hejjjgextxebp Bosgvo Cpxtgw

    Recruiting

    1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Aprepitant
    • Betamethasone
    • Epirubicin Hydrochloride
    Belgium Norway Sweden
Previous Page
1 … 4 5 6 7 8 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!